Based on these findings, we concluded that SH treatment post-myocardial infarction could attenuate post-infarct remodeling, alleviate cardiac inflammatory and fibrotic responses, and the underlying mechanism was related to activating AMPK and suppressing NF-κB signal pathway. The gene discussed is NFKB1; the disease is myocardial infarction.